Advances in the Diagnosis and Treatment of Clear Cell Renal Cell Carcinoma

A panel of healthcare professionals, patients, and a patient advocate provide a discussion on advances in diagnosing, treating, and managing clear cell RCC through the lens of their own experiences.

EP. 1: Overview of Clear Cell RCC

March 30th 2022

Chung-Han Lee, M.D., provides background on clear cell renal cell carcinoma, including common symptoms and risk factors.

EP. 2: Receiving a Diagnosis of Metastatic RCC: A Patient’s Journey

March 30th 2022

Patient Meryl Uranga describes how she was diagnosed with metastatic clear cell renal cell carcinoma and the initial treatments she received.

EP. 3: Patient Education Resources for RCC

April 8th 2022

Bryan Lewis, president of KidneyCAN, explains how his organization supports the renal cell carcinoma community and where patients can find curated educational resources.

EP. 4: First-Line Treatment Options for Metastatic Clear Cell RCC

April 8th 2022

An overview of first-line treatment options for metastatic clear cell renal cell carcinoma.

EP. 5: A Patient’s Perspective on Choosing Systemic Therapy for Metastatic RCC

April 19th 2022

Patients with clear cell renal cell carcinoma speak to their experiences with systemic treatments.

EP. 6: Lenvatinib + Pembrolizumab for the Treatment of Metastatic Clear Cell RCC

April 19th 2022

A review of clinical trial data on combination treatments for clear cell renal cell carcinoma.

EP. 7: Factors for Consideration in RCC Treatment Decision-Making

April 21st 2022

An oncologist describes the necessity of discussing options with a patient when picking a treatment approach for clear cell renal cell carcinoma.

EP. 8: Role of Nurses in the Multidisciplinary Management of RCC

April 21st 2022

Clinical nurse Kiran Virdee explains why a multidisciplinary treatment approach to clear cell renal cell carcinoma is beneficial.

EP. 9: Adverse Events Associated with IO-TKI Therapies in Metastatic Clear Cell RCC

May 2nd 2022

An overview of side effects commonly seen with lenvatinib plus pembrolizumab for the treatment of clear cell renal cell carcinoma.

EP. 10: Patient Experience with Systemic Therapy-Related Toxicities in Metastatic RCC

May 2nd 2022

Meryl Uranga describes her personal experience with managing the side effects of treatment for clear cell renal cell carcinoma.

EP. 11: Quality-of-Life with Systemic Therapies in Metastatic Clear Cell RCC

May 5th 2022

A look at how to consider quality-of-life clinical trial and patient-reported data when treating clear cell renal cell carcinoma with combination therapies.

EP. 12: The Importance of Patients Advocating for Themselves During Their RCC Journey

May 5th 2022

Meryl Uranga describes her path with metastatic clear cell renal cell carcinoma after first treatment, and how it has affected her outlook on her life and future.

EP. 13: Unmet Needs and Future Perspectives in the Treatment of RCC

May 5th 2022

Bryan Lewis, president of KidneyCAN, and Chung-Han Lee, MD, describe unmet needs and future perspectives in the treatment of renal cell carcinoma.